Orca Bio Stock

orcabio.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $416.19MM

Orca Bio is the developer of high-precision allogeneic cell therapies designed to safely replace patients’ diseased blood and immune system with a healthy one.

Register for Details

For more details on financing and valuation for Orca Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Orca Bio.

Register Today

Team

Management Team

Ivan Dimov Ph.D
Co-Founder & Chief Executive Officer
Dan Kirby
Chief Commercial Officer
Jeroen Bekaert
Chief Operating Officer
Nathaniel Fernhoff Ph.D
Co-Founder & Chief Science Officer

Board Members

Alex Kolicich
8VC
Jonathan MacQuitty Ph.D
Lightspeed Venture Partners

Other companies like Orca Bio in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B
Updated on: Oct 3, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.